Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, October 26, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

The Future of Targeted Therapy in Rheumatology: Biologics or Small Molecules?
Tuesday, August 12, 2014
While biologics can modulate extracellular protein-protein interactions, intracellular processes can be more effectively targeted by small molecules.

Baxter Opens its First Biologics Facility in Asia
Thursday, August 07, 2014
Singapore-based facility enhances the company’s global capabilities to support the treatment needs of hemophilia patients worldwide.

Redbiotec, GE Healthcare CMV Vaccine Collaboration
Tuesday, August 05, 2014
Companies combine expertise to produce cytomegalovirus vaccine candidates.

Roche to Acquire Santaris Pharma
Tuesday, August 05, 2014
Acquisition to expand Roche's discovery and development of RNA-targeting medicines.

International Bioprinting Congress
Monday, August 04, 2014
Select Biosciences South East Asia is pleased to report on the success of the inaugural International Bioprinting Congress, which took place at the Biopolis, Singapore on the 24-25 July 2014.

Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer
Thursday, July 31, 2014
Baxter will sell its commercial vaccines businesses to Pfizer for $635 million.

Malvern Completes Acquisition of MicroCal
Friday, July 25, 2014
Company announces purchase of Archimedes product from Affinity Biosensors.

MRC Technology Announces Humanization of Anti-Tau Monoclonal Antibody
Tuesday, July 22, 2014
Antibody inhibits Tau aggregation involved in the pathology of Alzheimer’s and other neurodegenerative diseases.

Genticel’s Phase II Study with ProCervix Passes the Halfway Mark for Patient Recruitment
Friday, July 18, 2014
The trial is proceeding as planned, after first DSMB (Data and Safety Monitoring Board) review.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 1133
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to